Furthermore, You et al. [226] demonstrated that CCL5 is highly expressed in OCSCs compared to non-CSCs, and its receptor, CCR5, is upregulated on regulatory T cells (Tregs) in ovarian cancer patients. This evidence concerns the gene CCL5 and ovarian cancer.